These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 26945158

  • 21. Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).
    Bays HE, Braeckman RA, Ballantyne CM, Kastelein JJ, Otvos JD, Stirtan WG, Soni PN.
    J Clin Lipidol; 2012; 6(6):565-72. PubMed ID: 23312052
    [Abstract] [Full Text] [Related]

  • 22. MEK-ERK inhibition corrects the defect in VLDL assembly in HepG2 cells: potential role of ERK in VLDL-ApoB100 particle assembly.
    Tsai J, Qiu W, Kohen-Avramoglu R, Adeli K.
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):211-8. PubMed ID: 17038630
    [Abstract] [Full Text] [Related]

  • 23. Effect of TAK-085 on Low-density Lipoprotein Particle Size in Patients with Hypertriglyceridemia: A Double-blind Randomized Clinical Study.
    Tatsuno I, Kudou K, Kagawa T.
    Cardiovasc Ther; 2015 Dec; 33(6):317-23. PubMed ID: 26222126
    [Abstract] [Full Text] [Related]

  • 24. Atorvastatin improves postprandial lipoprotein metabolism in normolipidemlic subjects.
    Parhofer KG, Barrett PH, Schwandt P.
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4224-30. PubMed ID: 11095458
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Low-density lipoprotein (LDL)-antioxidant lignans from Myristica fragrans seeds.
    Kwon HS, Kim MJ, Jeong HJ, Yang MS, Park KH, Jeong TS, Lee WS.
    Bioorg Med Chem Lett; 2008 Jan 01; 18(1):194-8. PubMed ID: 17998162
    [Abstract] [Full Text] [Related]

  • 31. Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL.
    Winkler K, Weltzien P, Friedrich I, Schmitz H, Nickell HH, Hauck P, Hoffmann MM, Baumstark MW, Wieland H, März W.
    Exp Clin Endocrinol Diabetes; 2004 May 01; 112(5):241-7. PubMed ID: 15146369
    [Abstract] [Full Text] [Related]

  • 32. Ethyl all-cis-5,8,11,14,17-icosapentaenoate modifies the biochemical properties of rat very low-density lipoprotein.
    Mizuguchi K, Yano T, Ishibashi M, Masada A, Mizota M, Saito Y.
    Eur J Pharmacol; 1993 Apr 28; 235(2-3):221-7. PubMed ID: 8508903
    [Abstract] [Full Text] [Related]

  • 33. Effects of oils rich in eicosapentaenoic and docosahexaenoic acids on the oxidizability and thrombogenicity of low-density lipoprotein.
    Mesa MD, Buckley R, Minihane AM, Yaqoob P.
    Atherosclerosis; 2004 Aug 28; 175(2):333-43. PubMed ID: 15262190
    [Abstract] [Full Text] [Related]

  • 34. Oral administration of policosanol inhibits in vitro copper ion-induced rat lipoprotein peroxidation.
    Menéndez R, Fraga V, Amor AM, González RM, Más R.
    Physiol Behav; 1999 Aug 01; 67(1):1-7. PubMed ID: 10463622
    [Abstract] [Full Text] [Related]

  • 35. Fenofibrate protects lipoproteins from lipid peroxidation: synergistic interaction with alpha-tocopherol.
    Chaput E, Maubrou-Sanchez D, Bellamy FD, Edgar AD.
    Lipids; 1999 May 01; 34(5):497-502. PubMed ID: 10380122
    [Abstract] [Full Text] [Related]

  • 36. Effect of lipid transfer activity and lipolysis on low density lipoprotein (LDL) oxidizability: evidence for lipolysis-generated non-esterified fatty acids as inhibitors of LDL oxidation.
    Viens L, Athias A, Lizard G, Simard G, Gueldry S, Braschi S, Gambert P, Lallemant C, Lagrost L.
    J Lipid Res; 1996 Oct 01; 37(10):2179-92. PubMed ID: 8906595
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Circulation; 2004 Sep 14; 110(11):1406-12. PubMed ID: 15353498
    [Abstract] [Full Text] [Related]

  • 39. Time-course studies by synchrotron X-ray solution scattering of the structure of human low-density lipoprotein during Cu(2+)-induced oxidation in relation to changes in lipid composition.
    Meyer DF, Nealis AS, Macphee CH, Groot PH, Suckling KE, Bruckdorfer KR, Perkins SJ.
    Biochem J; 1996 Oct 01; 319 ( Pt 1)(Pt 1):217-27. PubMed ID: 8870672
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.